TCL Archive Deflecting Earmarks, NCI Advisors Lay Out Research Opportunities In Breast, Prostate February 26, 1999
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
